PTCHFOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as PRTCY
PureTech Health plc
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 29, 2026
$1.48+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
PureTech Health plc income statement
Ratios
Latest available, balances at Dec 31, 2025
Profitability, FY2025
- Gross margin
- –
- Operating margin
- -2114.8%
- Net margin
- -2355.4%
- Return on equity, FY2025
- -30.2%
Financial strength
- Current ratio
- 6.59
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 545.2%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –